Review of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C

Kyle J Wilby; Nilufar Partovi; Jo-Ann E Ford; Erica D Greanya; Eric M Yoshida

doi:10.1155/2012/751057

Canadian Journal of Gastroenterology (Jan 2012)

Review of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C

Kyle J Wilby,
Nilufar Partovi,
Jo-Ann E Ford,
Erica D Greanya,
Eric M Yoshida

Affiliations

Kyle J Wilby: University of British Columbia, Canada
Nilufar Partovi: University of British Columbia, Canada
Jo-Ann E Ford: BC Hepatitis Program, Gordon & Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada
Erica D Greanya: University of British Columbia, Canada
Eric M Yoshida: University of British Columbia, Canada

DOI: https://doi.org/10.1155/2012/751057
Journal volume & issue: Vol. 26, no. 4
pp. 205 – 210

Abstract

Read online

OBJECTIVE: To summarize and evaluate the published literature pertaining to boceprevir and telaprevir, and to provide clinicians with suggestions for use in patients with chronic hepatitis C infection.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal